New Portfolio - New Portfolio
Gabriel Diacakis
New PortfolioIndividual Investor
Ranked #156,163 out of 858,971 TipRanks' Investors
Success Rate
108 out of 208
profitable transactions
profitable transactions
Average Return
44.03%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 4.78%
6-Month Return▲ 1.93%
12-Month Return▲ 42.50%
YTD Return▲ 1.41%
Total Return▲ 95.80%
Best Trade
Bio
A weighted risk investment not for the investor who wants to get a small profit and sell fast
Performance
12.88%0-12.88%
▲ 12.88%
▲ 3.56%
▲ 3.52%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 1.74%
Oct 2025
▼ 3.68%
▲ 0.19%
▲ 4.12%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 0.57%
Dec 2025
▲ 4.06%
▲ 1.47%
▼ 1.55%
Jan 2026
▼ 1.12%
▼ 0.86%
▲ 3.95%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 5.84%
Mar 2026
▲ 7.53%
▲ 5.50%
▲ 5.25%
Apr 2026
▲ 12.88%▲ 3.56%▲ 3.52%
▲ 10.96%▲ 2.38%▲ 1.74%
▼ 3.68%▲ 0.19%▲ 4.12%
▼ 0.10%▲ 0.08%▼ 0.57%
▲ 4.06%▲ 1.47%▼ 1.55%
▼ 1.12%▼ 0.86%▲ 3.95%
▲ 0.60%▼ 4.94%▼ 5.84%
▲ 7.53%▲ 5.50%▲ 5.25%
Recent Activity
Luminar Technologies
―
▼ 100.00%
2
Close
Apr 07, 2026
Hologic
―
▲ 23.73%
2
Close
Apr 06, 2026
ON24
―
▼ 83.06%
2
Close
Apr 01, 2026
Genfit SA
―
▲ 87.49%
2
Close
Mar 09, 2026
Dynavax
―
▲ 176.90%
3
Close
Feb 09, 2026
AstraZeneca
―
▲ 102.87%
3
Close
Jan 30, 2026
AstraZeneca
4.09%
▲ 9.23%
1
Open
Jan 30, 2026
iCAD
―
▼ 78.58%
2
Close
Jul 16, 2025
Radnet
0%
▼ 1.80%
1
Open
Jul 16, 2025
Vroom
―
▼ 99.86%
2
Close
Jan 14, 2025
TFF Pharmaceuticals
―
▼ 99.96%
2
Close
Dec 12, 2024
Eiger Biopharmaceuticals
―
▼ 97.43%
2
Close
Oct 01, 2024
Phasebio Pharmaceuticals
―
▼ 99.49%
2
Close
Oct 01, 2024
G1 Therapeutics
―
▼ 76.74%
3
Close
Sep 17, 2024
Deciphera Pharmaceuticals
―
▼ 48.54%
2
Close
Jun 10, 2024
Bristol-Myers Squibb
0%
▲ 45.26%
1
Open
May 17, 2024
Textainer Group Holdings
―
▲ 147.10%
2
Close
Mar 14, 2024
Orchard Therapeutics
―
▼ 72.71%
2
Close
Jan 24, 2024
Athenex
―
▼ 99.99%
3
Close
Oct 03, 2023
Arconic
―
▲ 90.78%
2
Close
Aug 18, 2023